Wolfe Research Issues Pessimistic Forecast for CVS Health (NYSE:CVS) Stock Price

CVS Health (NYSE:CVS) had its price target decreased by equities research analysts at Wolfe Research from $100.00 to $97.00 in a note issued to investors on Monday,MarketScreener reports. The firm currently has an “outperform” rating on the pharmacy operator’s stock. Wolfe Research’s target price would indicate a potential upside of 19.84% from the company’s current price.

Several other research analysts have also issued reports on CVS. UBS Group reissued an “outperform” rating on shares of CVS Health in a research note on Wednesday, December 10th. Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. Barclays boosted their price target on shares of CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Argus dropped their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Finally, Wells Fargo & Company decreased their target price on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $94.77.

CVS Health Stock Performance

NYSE CVS traded up $1.04 on Monday, hitting $80.94. The stock had a trading volume of 667,433 shares, compared to its average volume of 9,276,245. The company’s 50-day moving average is $78.39 and its two-hundred day moving average is $77.29. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The stock has a market cap of $102.98 billion, a price-to-earnings ratio of 58.75, a P/E/G ratio of 0.83 and a beta of 0.49. CVS Health has a one year low of $58.35 and a one year high of $85.15.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue was up 8.2% compared to the same quarter last year. During the same period last year, the business posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, analysts expect that CVS Health will post 5.89 earnings per share for the current year.

Institutional Trading of CVS Health

A number of institutional investors have recently bought and sold shares of CVS. National Pension Service raised its holdings in CVS Health by 3.1% in the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock valued at $301,532,000 after buying an additional 119,189 shares during the last quarter. AE Wealth Management LLC increased its holdings in shares of CVS Health by 6.2% during the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock valued at $19,391,000 after acquiring an additional 14,983 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock valued at $16,971,000 after buying an additional 22,653 shares in the last quarter. Alpha Omega Wealth Management LLC lifted its stake in CVS Health by 12.3% during the 3rd quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its position in CVS Health by 186.6% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock worth $30,568,000 after acquiring an additional 258,050 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.